Advances in mesenchymal stem cell therapy for lupus nephritis

doi:10.4252/wjsc.v17.i8.104930

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 8

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (20)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-3) series.

Item

Count

PDF

HTML

Figures (1-1)

Tables (1-3)

Sum=20

Aug 26, 2025 (publication date) through Aug 21, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Stem Cells

ISSN

1948-0210

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Stem Cells. Aug 26, 2025; 17(8): 104930
Published online Aug 26, 2025. doi: 10.4252/wjsc.v17.i8.104930

Open in New Tab Full Size Figure Download Figure

Figure 1 Immunomodulatory mechanisms of mesenchymal stem cell therapy for lupus nephritis. The red arrow represents a downward adjustment and the green arrow represents an upward beneficial adjustment. IFN-γ: Interferon-γ; IL: Interleukin; TNF-α: Tumor necrosis factor-α; TGF-β: Transforming growth factor-β; BAFF: B-cell activating factor; Th: T helper; DCs: Dendritic cells; M-CSF: Macrophage-colony stimulating factor.

Citation: Liu L, Behera TR, Wang QJ, Shen QQ. Advances in mesenchymal stem cell therapy for lupus nephritis. World J Stem Cells 2025; 17(8): 104930
URL: https://www.wjgnet.com/1948-0210/full/v17/i8/104930.htm
DOI: https://dx.doi.org/10.4252/wjsc.v17.i8.104930